BioSpace News Archive

Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET.

Ribbon Biolabs, the DNA synthesis company, announced its participation in the SynBioBeta 2023 conference, held from May 23 to May 25, 2023, in Oakland, CA.

Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy, a revolutionary new treatment modality for cancer, launched out of stealth concurrent with its first preclinical data presentation at the ASGCT 26th Annual Meeting, taking place in Los Angeles, May 16-20th.

EDAP TMS SA, the global leader in robotic energy-based therapies, announced unaudited financial results for the first quarter ended March 31, 2023.

Sania Therapeutics launches today by unveiling its suite of proprietary patented platforms at the American Society of Gene & Cell Therapy (ASGCT) conference.

enGene, Inc. and Forbion European Acquisition Corp. today announced that they have entered into a definitive business combination agreement.

TScan Therapeutics, Inc. today announced a poster presentation highlighting preliminary data from the Phase 1 umbrella clinical trial evaluating TSC-100 and TSC-101 at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting 2023.

Viatris Inc. ( NASDAQ : VTRS ), a global healthcare company, today announced the company will participate in the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA on Tuesday, June 13, 2023.

Novadip Biosciences SA today announced that the first patient has been implanted with its investigational tissue regeneration product, NVD-003, in its Phase 1b/2a clinical trial treating four patients with Congenital Pseudarthrosis of Tibia (CPT).

Spectrum Pharmaceuticals, Inc. announced today that on May 16, 2023, the Company received a written notification from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (Nasdaq) that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).